A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
29 Sep 2026 · 02:54 CST Terminal Access 终端入口 →
002399.SZ深圳证券交易所 · 主板 Main

Shenzhen Hepalink Pharmaceutical Group 海普瑞

Chemical Pharmaceuticals 化学制药
¥9.66+¥0.08 · +0.84%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥9.63
High 最高
¥9.70
Low 最低
¥9.57
Prev Close 昨收
¥9.58
Volume 成交量
323.1万股
Turnover 成交额
¥3,111.2万
Mkt Cap 总市值
¥142亿
P/E 市盈率
69.8×
Recent Activity 近期动态All Filings 全部公告 →

2 significant filings since 1 Jun 2026: 1 on guarantee or financial assistance and 1 on dividend. The latest, on 29 Aug 2026: 关于调整向银行申请授信额度及提供担保的公告.
自 1 Jun 2026 起有 2 份重大公告:guarantee or financial assistance 1 份、dividend 1 份。最新一份(29 Aug 2026):关于调整向银行申请授信额度及提供担保的公告。

Price History 价格走势

5 sessions 个交易日, 21 Sep to 28 Sep 2026 · Live one-minute prices 实时分钟价格 · High 最高 ¥9.88 · Low 最低 ¥9.37 · +0.84% on the previous close of ¥9.58 较昨收
9.409.509.609.709.80
Volume 成交量
3,302
21 Sep22 Sep23 Sep24 Sep28 Sep

Against Its Own History 与自身历史比较

69.8×
Median 中值 43.2× · Range 区间 24.3× to 64.9× · 7 periods 期
1.19×
Median 中值 1.35× · Range 区间 1.02× to 1.44× · 10 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥8.98¥0.1464.9×¥8.131.10×
31 Mar 2026 一季报¥11.34¥0.2643.7×¥8.301.37×
31 Dec 2025 年报¥11.79¥0.2449.5×¥8.201.44×
30 Sep 2025 三季报¥11.96¥0.2941.8×¥8.431.42×
30 Jun 2025 中报¥11.91¥0.2843.2×¥8.291.44×
31 Mar 2025 一季报¥11.11¥0.4425.1×¥8.371.33×
31 Dec 2024 年报¥10.69¥0.4424.3×¥8.281.29×
30 Sep 2024 三季报¥11.40——¥8.271.38×
30 Jun 2024 中报¥8.67——¥8.271.05×
31 Mar 2024 一季报¥8.35——¥8.221.02×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA